The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture
- PMID: 8905032
- DOI: 10.1093/oxfordjournals.annonc.a010723
The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture
Abstract
Background: Cardiotoxicity still remains an unexplained toxic manifestation of 5-fluorouracil (5-FU). Clinical and experimental data suggest that endothelium of coronary arteries could be involved in the pathophysiological mechanisms of the syndrome. In order to further explain 5-FU induced cardiotoxicity, we investigated the influence of this drug on endothelial cells (EC) in a cell culture model.
Materials and methods: The influence of 5-FU on EC, with respect to DNA synthesis, cell death and release of prostacyclin by endothelial cells (EC) was studied. For comparison, we tested methotrexate (MTX), an antimetabolite without cardiotoxic properties, in the same way. Human endothelial cell lines (HEC) and bovine endothelial cells (BEC) were incubated with increasing concentrations of 5-FU and MTX for 48 hours. (3H)thymidine incorporation, total cellular protein, loss of (3H)thymidine from prelabelled cells and 6-keto-prostaglandin F1 were measured.
Results: DNA synthesis decreased significantly in both HEC and BEC, and the release of prostacyclin by BEC increased significantly when incubated with 5-FU. This effect was not seen with MTX.
Conclusion: The results indicate specific susceptibility of benign EC to 5-FU. Such susceptibility was confirmed by the release of prostacyclin by the BEC, indicating leakage secondary to EC injury.
Similar articles
-
5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow.Anticancer Res. 1999 Mar-Apr;19(2A):985-8. Anticancer Res. 1999. PMID: 10368642
-
Effect of 25-hydroxycholesterol on cytotoxicity and prostacyclin production in cultured human umbilical arterial endothelial cells.Eicosanoids. 1992;5(1):29-34. Eicosanoids. 1992. PMID: 1419077
-
Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate.Eur J Cancer Clin Oncol. 1984 May;20(5):651-7. doi: 10.1016/0277-5379(84)90012-9. Eur J Cancer Clin Oncol. 1984. PMID: 6234172
-
Cardiotoxicity of 5-fluorouracil.Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):1-5. doi: 10.2174/187152506775268785. Cardiovasc Hematol Agents Med Chem. 2006. PMID: 16529545 Review.
-
[Cardiotoxicity of 5-fluorouracil].Bull Cancer. 2004 Nov;91 Suppl 3:154-8. Bull Cancer. 2004. PMID: 15899622 Review. French.
Cited by
-
Venous thromboembolism (VTE) and glioblastoma.J Neurooncol. 2015 Aug;124(1):87-94. doi: 10.1007/s11060-015-1805-2. Epub 2015 May 19. J Neurooncol. 2015. PMID: 25985958
-
Approach to chemotherapy-associated thrombosis.Vasc Med. 2015 Apr;20(2):153-61. doi: 10.1177/1358863X14568705. Vasc Med. 2015. PMID: 25832603 Free PMC article. Review.
-
Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity.Curr Treat Options Cardiovasc Med. 2016 Jul;18(7):44. doi: 10.1007/s11936-016-0465-7. Curr Treat Options Cardiovasc Med. 2016. PMID: 27181399 Review.
-
5-FU induced cardiotoxicity: case series and review of the literature.Cardiooncology. 2019 Sep 6;5:13. doi: 10.1186/s40959-019-0048-3. eCollection 2019. Cardiooncology. 2019. PMID: 32154019 Free PMC article. Review.
-
The effect of propolis on 5-fluorouracil-induced cardiac toxicity in rats.Sci Rep. 2022 May 23;12(1):8661. doi: 10.1038/s41598-022-12735-y. Sci Rep. 2022. PMID: 35606482 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources